Browsing by Subject "Pharm.D."
Now showing 1 - 12 of 12
- Results Per Page
- Sort Options
Item Clinical Pharmacy Clerkship in Pakistan: A leap from paper to practice(University of Minnesota, College of Pharmacy, 2011) Aslam, Nousheen; Ahmed, Khwaja ZafarThis is the first article of its type to describe the advances taking place in clinical pharmacy education in Pakistan. The Pharmacy Council of Pakistan has developed a five-year Pharm.D program to replace the four-year B.Pharm degree. Completing clinical pharmacy clerkships is a prerequisite for receiving the Pharm.D degree. To meet this requirement, Ziauddin College of Pharmacy has developed a specialized clerkship program for its 4th and 5th year students. The College is fortunate to be linked with well developed tertiary care hospitals at three prime locations in the in the metropolitan city of Karachi, which provides opportunity for the students to gain exposure to real life situations and work with patients. The article presents an account of the efforts taken for development of the clinical pharmacy clerkship program, the problems encountered during its development, and the main outcomes of a clerkship program.Item Interview with Delores "Dee" Weaver(University of Minnesota, 2013-08-25) Klaffke, Lauren E.; Weaver, Delores "Dee"Delores Weaver begins her interview by elaborating on her education in South Dakota and then at the University of Minnesota. She then reflects on her military service in the Navy as part of the WAVES and her husband’s service in the Air Force. Mrs. Weaver then discusses her work as a flight attendant, her time doing procedure audits for Bechtel Company in San Francisco, and how she met her husband, Lawrence Weaver. She then reviews her husband’s early career, as an adjunct at Butler while working for Pitman-Moore, which became part of Dow Chemical, and his interest in pursuing a career in pharmacy. In reflecting on her husband’s work as dean of the College of Pharmacy at the University of Minnesota, Mrs. Weaver discusses all of the following regarding her husband’s work: the problems he faced with finding adequate space; creation of the PharmD program; the changing role of the pharmacist; his work on the formation of the Academic Health Center (AHC); lobbying the State Legislature; serving as vice president of professional relations for the Pharmaceutical Manufacturers of America (PMA); and his support of orphan drug work. She then discusses her own work as a volunteer at University Hospital, the couple’s return to the Twin Cities when Dr. Weaver served as temporary dean of the School of Pharmacy from 1994 to 1996, Dr. Weaver’s leadership style, and funding for the School. She concludes the interview by reviewing Dr. Weaver’s relationships with various vice presidents of the AHC and his work on orphan drugs.Item Interview with Frank Cerra(University of Minnesota, 2014-07-31) Cerra, Frank B.; Tobbell, DominiqueDr. Frank Cerra begins part one of his interview by describing his undergraduate education at SUNY Binghamton, his medical education at Northwestern University Medical School, and his residency at SUNY Buffalo. He then describes his recruitment to the University of Minnesota, his early goals, and his growing administrative roles. He describes the leadership implications of investigations into Antilymphocyte Globulin (ALG) on the Medical School and the merging of University Hospital with Fairview Health Services. He then discusses the following topics: his interest in surgery; the culture of the University of Minnesota’s Department of Surgery; his work with the pharmaceutical industry and the College of Pharmacy; his work developing a critical care program at the University; and his relationships with the hospital directors, hospital nursing, and the School of Nursing. In part of two his interview, Dr. Cerra intersperses reflections on finances and relations among different levels of administration in the University, the AHC, and University Hospital. He also discusses the following topics: his relationship with Neal Gault; strategic and long-range planning; the goals of the AHC; the formation of University of Minnesota Physicians; the establishment of the Biomedical Ethics Center (later the Center for Bioethics) and the Masonic Cancer Center; the investigations into ALG and Dr. John Najarian; the establishment of the Center for Drug Design; William Brody as Provost of the AHC and issues surrounding faculty tenure; and the establishment of the Institute for Health Informatics. In part three of his interview, Dr. Cerra expands on the decision to merge University Hospital with Fairview Health Services, particularly focusing on logistics, culture, and reception. He also discusses failed attempts to create a unified children’s hospital in the Twin Cities. He then reflects on the following topics: the major challenges and achievements of his tenure as senior vice president; the merging of the positions of Senior Vice President of Health Sciences and Dean of the Medical School; the creation of the Clinical and Translational Science Institute and the Biomedical Discovery District; and the medical device industry in Minnesota. He concludes by describing the University of Minnesota and Mayo Clinic partnership in research.Item Interview with Karlind T. Moller(University of Minnesota, 2013-04-26) Klaffke, Lauren E.; Moller, Karlind T.Karlind Moller begins his interview with a reflection on his upbringing and early education. He then discusses how he came to the field of speech pathology and particularly, speech pathology in relation to the cleft palate, relating his experiences in the Cleft Palate Clinic and at the National Institute for Dental Research. He emphasizes the interdisciplinary nature of the Cleft Palate Clinic. He also discusses his experiences publishing with the University of Minnesota Press, his committee work, particularly his work on the Admissions Committee and Minority Student Committee, his work with out-of-state patients, the work of the Cleft Palate Clinic in consulting on treatment, and the completion of the building of the Dental School facilities in the 1970s. Dr. Moller then reflects on his cleft palate work in Guatemala, funding for the Cleft Palate Clinic, the relationship between the Dental School and the Department of Communication Disorders, the Cleft Palate Clinic team, and issues with the state legislature and speech pathologist licensing. He also discusses his teaching, work with dental hygienists, the culture of the Dental School, Dr. Erwin Schaeffer’s tenure as dean, the relationship of the Cleft Palate Clinic with other schools in the AHC, the tenures of Dr. Richard Oliver and Richard Elzay as deans, the threatened closure of the Dental School in 1988, retrenchment, work with the state legislature and the insurance industry over cleft palate correction, the vice presidents for the AHC in the 1990s, and the tenure of Dr. Michael Till as dean. He concludes by discussing additional figures of importance in the Dental School’s history.Item Interview with Lowell Anderson(University of Minnesota, 2012-08-01) Tobbell, Dominique A.; Anderson, LowellLowell Anderson begins his interview with a reflection on his early life and education, highlighting his experience earning a bachelor’s degree in pharmacy from the University of Minnesota. He describes the profession’s receptiveness to female pharmacists, his recollections of the Kefauver Hearings regarding prescription drug pricing in the early 1960s, and the impact of managed care on pharmacy. He goes on to discuss his professional goals; his time at Walgreen’s as a pharmacy student; his early career, including time at Northwestern Hospital and the State Department of Administration; and his experience of ownership of pharmacies in Falcon Heights (1966) and White Bear Lake. Within this discussion, he reflects on how relationships between health care professionals and pharmacists change in different venues, the differences between a chain pharmacy and a privately owned pharmacy, building community relationships, generic substitution, the patient package insert, patient expectations regarding drug advice from doctors and pharmacists, the function of Pharmacy Benefit Managers. The conversation then transitions to the Academic Health Center and Mr. Anderson’s contributions to the College of Pharmacy. The following topics are discussed: the introduction of clinical pharmacy in the College; relations between basic scientists and professional pharmacists in the College; relations among schools and colleges in the AHC; the potential creation of the Pharmacy Technician Program; the threatened shortage of pharmacists; the creation of the Department of Social and Administrative Pharmacy; the development of pharmaceutical care practice; and the Center for Leading Healthcare Change. He concludes his interview with current policy issues in which pharmacists should adopt a larger role.Item Interview with Neal A. Vanselow(University of Minnesota, 2013-07-10) Tobbell, Dominique A.; Vanselow, Neal A.Dr. Neal Vanselow begins his interview by reflecting on his education and training at the University of Michigan and his internship at Minneapolis General Hospital (now Hennepin County Medical Center). He then discusses his tenure as dean at the University of Arizona College of Medicine and his move to the University of Nebraska Medical Center in Omaha. He relates the reasons for his move to the University of Minnesota Academic Health Center (AHC). Concerning the University’s AHC, Dr. Vanselow describes all of the following: the culture of the AHC particularly town/gown relationships; the relationship between the AHC and the rest of the University; the relationship between the AHC and Central Administration; relations among units in the health sciences; the incorporation of the College of Veterinary Medicine into the AHC; and Ken Keller’s Commitment to Focus and the threatened closure of the Dental School and the College of Veterinary Medicine. Reflecting on larger trends in healthcare and health education, he discusses: efforts to admit more minority students; issues regarding the rising costs of hospital care and the impact on University Hospital; faculty practice; retrenchments; the creation of the Biomedical Ethics Center; and the issues surrounding the University’s production and sale of Antilymphocyte Globulin (ALG). Dr. Vanselow also describes the tenures of the presidents of the University and the regents with which he worked; his work with the Legislature; the differences between a private and public academic health center; and his time on the board of the Association of Academic Health Centers. He concludes his interview with a reflection on his experiences as part of the Institute of Medicine’s Committee on the Future of Primary Care and the Continuing Evaluation Panel of the American International Health Alliance.Item Interview with Norrie Thomas(University of Minnesota, 2013-11-21) Klaffke, Lauren E.; Thomas, NorrieNorrie Thomas was born in Detroit, Michigan but grew up in Rochester, Minnesota. She completed two years at a junior college in Rochester and transferred to the University of Minnesota in 1971. She earned her bachelor’s in pharmacy in 1976. She worked as a staff pharmacist at Saint Mary’s Hospital and the Mayo Clinic before returning to the University of Minnesota as a graduate student. She earned her master’s and doctorate in pharmacy administration in 1980 and 1983, respectively. She made important strides in developing the field of pharmacy benefit management (PBM) over the course of her career, co-founding one of the first PBM companies, Clinical Pharmacy Advantage, in 1990. Over the course of her career, Dr. Thomas has held senior management positions at all of the following companies: MedCenters Health Plans, Aetna, McKesson, PCS, Eli Lilly, St. Jude Medical, Schering-Plough, and Magellan Health Services. She also helped establish the Academy of Managed Care Pharmacy. From 2009 to 2010, Dr. Thomas served as an adjunct professor at the University, coordinating Dialogues in Managed Care Pharmacy Leadership, which sought to highlight leadership within the pharmacy profession. She currently serves president and managing director of Manchester Square Group.Item Interview with Philip Portoghese(University of Minnesota, 2012-06-14) Tobbell, Dominique A.; Portoghese, PhilipDr. Portoghese begins part one of his interview with a review of his education at Columbia University and then the University of Maryland. He briefly discusses his military service in the Korean War, his Master’s work at Columbia, and then his move to the University of Wisconsin-Madison for doctoral work on cancer research. He then relates his recruitment to the Department of Medicinal Chemistry at the University of Minnesota in 1961 and his changing research interests in analgesic receptors. Dr. Portoghese then discusses his childhood interest in chemistry, relating several personal anecdotes, and how this led to his interest in pharmacy. He shares his recollections of the College of Pharmacy when he first arrived at the University in 1961, Lawrence Weaver’s tenure as dean, changes in the field of medicinal chemistry, and changes in the structure of the Department of Medicinal Chemistry over the course of his career at the University. In part two of his interview, Dr. Portoghese offers his impressions of the creation of the Academic Health Center and the College of Pharmacy’s move to Weaver-Densford Hall. He discusses relations between the Department of Medicinal Chemistry and the Pharmacology Department, changes in concepts of intellectual property at the University, Dr. Robert Vince’s development of Ziagen, his own research on analgesic receptors, his continuous funding by the NIH, corporate interest in biochemical mechanisms, his development of different compounds as research tools, and industry support for drug research. He then discusses his time as chair of the Department of Medicinal Chemistry, administrative support for the Department, and his time as editor of the Journal of Medicinal Chemistry. He ends his interview with the major technological innovations that have revolutionized the way research in medicinal chemistry is performed.Item Interview with Randall D. Seifert(University of Minnesota, 2013-08-05) Klaffke, Lauren E.; Seifert, Randall D.Dr. Randall Seifert begins his interview by describing his early life and education, including his pursuit of a Pharm.D. and a postdoc in pharmacokinetics at the University of Minnesota. He then discusses his work in North Dakota. He reflects on changing trends in pharmacy hospital practice, ways to build sustainable clinical practices, and problems pharmacists face in smaller communities. He then describes the various positions he held in Southern California, particularly his work for California Clinical Trials and Health Net. He then describes his return to the University of Minnesota in 2005, including his work on the implementation of medication therapy management benefits for the City of Duluth and it adoption by U-Plan at the University of Minnesota. He then discusses the following topics: relationships between the Twin Cities and Duluth campuses of the College of Pharmacy; current trends in pharmacy education; efforts to recruit Native American students; his work with Marilyn Speedie and her leadership as dean; Frank Cerra’s leadership as vice president of the Academic Health Center; relations between medical and pharmacy students at UMN Duluth; collaborations between schools and colleges in the health sciences; and his work with the State Legislature. He concludes with his ideas for interprofessional communication in education.Item Interview with Robert J. Cipolle(University of Minnesota, 2012-06-12) Tobbell, Dominique A.; Cipolle, Robert J.Dr. Robert Cipolle begins his interview by briefly discusses his early life and education. He describes his time in the relatively new Pharm.D. at the University of Minnesota, his residency in Twin Cities area hospitals, and how the atmosphere of acceptance of the clinical pharmacy in Minnesota differed from areas. Dr. Cipolle then discusses the following topics regarding the changing culture surrounding pharmacy and pharmaceuticals: his move to University Hospital to support the growth of the clinical pharmacy program there; running the hospital pharmacy at Saint Paul-Ramsey; conflicts within the pharmacy therapeutics committee; equivalence, substitution, and prescriptive power issues in the 1970s, 1980s, and 1990s; the creation of the Peters Institute of Pharmaceutical Care; the practice of medication therapy management (MTM); the development of a billing system for clinical pharmacy; the training of clinical pharmacists as opposed to pharmacists working in dispensaries; and the introduction of the patient package insert. Following this discussion of larger trends, Dr. Cipolle reflects on his time in administration in the College of Pharmacy, including his time as associate dean under Gilbert Banker, changing the curriculum within the College, and his time as interim dean. He then describes the following: the relationship between the College and the Department of Pharmacology in the Medical School; the conversion to an all Pharm.D. program; the creation of the pharmacy program in Duluth; relations between the College and the basic sciences; failed discussions regarding the creation of a two-year pharmacy technician program; poison control and collaborations with the Medical and Nursing Schools; budget issues and long-range planning; funding from pharmaceutical companies; his time chairing the Conflict of Interest Committee; litigation surrounding the sale of Antilymphocyte Globulin (ALG); the creation of Medication Management Systems, Inc. Dr. Cipolle concludes with a reflection on changing demographics within pharmacy, the changing culture of pharmacy, and the naming of Unit F.Item Interview with Robert Vince(University of Minnesota, 2013-08-06) Klaffke, Lauren E.; Vince, RobertDr. Robert Vince begins his interview by describing his interest in science and medicine generally, his graduate research, and how he came to be professor at the University of Minnesota in the College of Pharmacy. In relation to his research while in the College, Dr. Vince discusses the following: his research on antibiotics and drugs with anticancer activity; the transition between exploring natural compounds and the creation of synthetic compounds within medicinal chemistry; issues he encountered in research attribution; his work on anti-herpes drugs; patenting issues in academia and the passage of the Bayh- Dole Act; and compound testing for activity against the AIDS virus. He then reflects on the development of the Center for Drug Design and developments within the Center. Discussing the history of the School of Pharmacy and the AHC more broadly, Dr. Vince covers the following topics: Lawrence Weaver’s tenure as dean; the clinical emphasis in the College of Pharmacy and the creation of the PharmD program; teaching and continuing education; the role of the PharmD in medicine; Gilbert Banker’s tenure as dean; the growth of the College of Pharmacy; the position of the Center for Drug Design within the AHC; and the merging of the positions of vice president of the AHC with dean of the Medical School. Dr. Vince concludes his interview with his recollections of former President George W. Bush’s visit to the University in July of 2002.Item Interview with Yusuf Abul-Hajj(University of Minnesota, 2012-08-06) Tobbell, Dominique A.; Abul-Hajj, Yusuf J.Dr. Yusuf Abul-Hajj begins his interview by reflecting on his education, his choice to pursue medicinal chemistry at the University of Wisconsin, the difficulties of transition and travel between Palestine and the United States, and the Arab community in Minneapolis. Dr. Abul-Hajj then describes his early career in the College of Pharmacy at the University of Minnesota, with particular attention to the clinical pharmacy movement, the creation of the Pharm.D. program, and problems that consequently arose within the basic science, research-oriented departments of the College. He then discusses the following topics: collaboration between the Department of Medicinal Chemistry and the Chemistry Department; the revival of social and administrative pharmacy; relations between clinical and basic science faculty in the College; collaborations between faculty in Medicinal Chemistry and faculty in the Medical School; the appointment of Gilbert Banker and his tenure as dean of the College; collaboration between Medicinal Chemistry and the pharmaceutical industry; his own research on estrogen and cancer; drug development in academia; and the creation of the Center for Drug Design.